肌萎缩侧索硬化
SOD1
超氧化物歧化酶
医学
运动神经元
歧化酶
疾病
内科学
氧化应激
作者
Miguel Oliveira Santos,Mamede de Carvalho
标识
DOI:10.1080/14737175.2024.2355983
摘要
Amyotrophic lateral sclerosis (ALS) is a rapidly progressive motor neuron disorder with a fatal outcome 3-5 years after disease onset due to respiratory complications. Superoxide dismutase 1 (SOD1) mutations are found in about 2% of all patients. Tofersen is a novel oligonucleotide antisense drug specifically developed to treat SOD1-ALS patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI